Credit Suisse Ag Applied Molecular Transport Inc. Transaction History

Credit Suisse Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$2.76 - $7.65 $35 - $99	13 New	13 $0
Q3 2021 Nov 12, 2021	SELL	$25.87 - $46.61 $163,343 - $294,295	-6,314 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$39.76 - $64.31 $57,970 - $93,763	-1,458 Reduced 18.76%	6,314 $289,000
Q1 2021 May 14, 2021	SELL	$30.5 - $74.14 $244,793 - $595,047	-8,026 Reduced 50.8%	7,772 $342,000
Q4 2020 Feb 12, 2021	BUY	$29.39 - $35.0 $464,303 - $552,930	15,798 New	15,798 $486,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.